PostEra Announces a Research Collaboration with Amgen to Discover Small Molecule Therapeutics using Artificial Intelligence

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

PostEra-Announces

More Like This

PR Newswire associated0

PostEra announces expansion to $610M in their AI drug discovery collaboration with Pfizer

Exscientia Announces Expansion of its Current Collaboration with Sanofi to Include Existing Exscientia Programme

AQEMIA FOUNDERS - Maximilien Levesque (CEO) and Emmanuelle Martiano (COO)

Aqemia Advances Epitranscriptomics Programs and Expands into Small-Molecule RNA Targeting with $7.4 Million Grant

BioMed X Institute Starts Its First Research Project With Sanofi on Artificial Intelligence for Drug Development

Orion Corporation Enters Collaboration With Evariste to Design Inhibitors of an Undisclosed Target

Maximilien Levesque, CEO and Cofounder of AQEMIA (left) and Emmanuelle Martiano Rolland, COO and Cofounder of AQEMIA (Photo: Business Wire)

AQEMIA Hits $100 Million Funding Milestone, Paving Way to Clinical Trials and Global Expansion Starting with London, UK

Carterra Announces its 2025 Symposia Series on Speeding Drug Discovery with AI/ML and Other New Technologies

PR Newswire associated0

Menarini Group and Insilico Medicine Enter a Second Exclusive Global License Agreement for an AI Discovered Preclinical Asset Targeting High Unmet Needs in Oncology